Entities / Person
Joel Becker.
clinical psychologist
- Reports this week
- 0
- Active events
- 0
- Connections
- 4
What's happening
Gone quiet
No new reports in 90+ days-
NeuroPace, Inc., which is listed on Nasdaq, has received FDA approval for its ECoG Assistant feature. Joel Becker serves as the company's CEO.Some support1 report
-
Joel Becker commented on CMS reimbursement decisions regarding NeuroPace's therapy.Some support1 report
-
Leadership changes at NeuroPace, Inc. on June 25, 2025, included appointing a new CFO, Rebecca Kuhn moving from CFO to advisory role, and Joel Becker taking the role of President and CEO.Speculative1 report
No events began in the chosen period. Widen it, or reset.
History
Events by the month they beganJune 2026
3 events- NeuroPace, Inc., which is listed on Nasdaq, has received FDA approval for its ECoG Assistant feature. Joel Becker serves as the company's CEO.
- Joel Becker commented on CMS reimbursement decisions regarding NeuroPace's therapy.
- Leadership changes at NeuroPace, Inc. on June 25, 2025, included appointing a new CFO, Rebecca Kuhn moving from CFO to advisory role, and Joel Becker taking the role of President and CEO.